Medinice S.A. Logo

Medinice S.A.

Develops and commercializes innovative, minimally invasive solutions for cardiology and cardiac surgery.

ICE | WAR

Overview

Corporate Details

ISIN(s):
PLMDNCE00016 (+2 more)
LEI:
259400LGO9UDV1Y18Z11
Country:
Poland
Address:
WARSZAWA HANKIEWICZA 2, 02-103 WARSZAWA
Sector:
Manufacturing
Industry:
Manufacture of medical and dental instruments and supplies

Description

Medinice S.A., founded in 2012, is a medical technology company focused on creating, developing, and commercializing innovative, safe, and minimally invasive solutions. The company specializes in the fields of cardiology and cardiac surgery. Its business model covers the entire development lifecycle, from prototyping and conducting preclinical and clinical trials to obtaining patents and commercializing the final products. Medinice manages a portfolio of over a dozen projects at various stages of development, including its PacePress and CoolCryo systems. The company is ISO 13485 certified, adhering to quality management standards for medical devices.

Social Media

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Medinice S.A. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-09-12 18:11
Capital/Financing Update
Otrzymanie deklaracji wsparcia od największego akcjonariusza - Content (PL)
Polish 987 bytes
2025-09-12 17:57
Audit Report / Information
Raport Biegłego Rewidenta ze skonsolidowanego sprawozdania finansowego
Polish 2.2 MB
2025-09-12 17:57
Audit Report / Information
Raport Biegłego Rewidenta z jednostkowego sprawozdania finansowego
Polish 2.3 MB
2025-09-12 17:57
Management Discussion and Analysis
Sprawozdanie Zarządu z działalności
Polish 1.4 MB
2025-09-12 17:57
Interim Report
Raport śródroczny GK Medinice za pierwsze półrocze 2025
Polish 1.2 MB
2025-09-03 17:28
Report Publication Announcement
Korekta raportu bieżącego ESPI nr 26/2025 - Content (PL)
Polish 1.1 KB
2025-09-03 17:01
Report Publication Announcement
Zmiana terminu publikacji raportu półrocznego za I półrocze 2025 r. - Content (…
Polish 1.4 KB
2025-08-19 11:31
Regulatory News Service
Pozytywne zakończenie Badania klinicznego PacePress. - Content (PL)
Polish 1.6 KB
2025-08-01 17:03
Report Publication Announcement
Zmiana terminu publikacji skonsolidowanego raportu półrocznego za pierwsze półr…
Polish 760 bytes
2025-07-30 12:55
Share Issue/Capital Change
Informacja o dacie rejestracji akcji serii L i akcji serii L1 w KDP - Content (…
Polish 1.0 KB
2025-07-29 13:33
Share Issue/Capital Change
Informacja o dopuszczeniu i wprowadzeniu akcji serii L oraz L1 do obrotu na ryn…
Polish 1.6 KB
2025-07-25 16:56
Registration Form
Informacja o warunkowej rejestracji akcji serii L i L1 w Krajowym Depozycie Pap…
Polish 1.4 KB
2025-07-07 12:41
Post-Annual General Meeting Information
Zawiadomienie formularz D
Polish 80.7 KB
2025-07-07 12:41
Major Shareholding Notification
Otrzymanie zawiadomienie sporządzonego na podstawie art. 69 ust. 1 lub 2 w zw.…
Polish 559 bytes
2025-07-07 12:40
Board/Management Information
Oświaczenie oraz życiorys R.D.
Polish 1.3 MB

Automate Your Workflow. Get a real-time feed of all Medinice S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Medinice S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Theradiag Logo
Develops IVD tests for biotherapy monitoring in autoimmune diseases and oncology.
France ALTER
TISSUE REGENIX GROUP PLC Logo
Develops regenerative biological products for orthopaedic and dental markets.
United Kingdom TRX
Developing disruptive spinal fixation devices for the vertebral surgery market.
United Kingdom N/A
Ulisse Biomed Logo
Provides a portable platform for rapid point-of-need genetic analysis and diagnostics.
Italy UBM
Viromed Medical Logo
Develops cold plasma tech for infection control, wound care, and air disinfection for healthcare.
Germany VMED
Vitrolife Logo
Global provider of medical devices and genetic testing services for the IVF treatment journey.
Sweden VITR
Xvivo Perfusion Logo
Develops ex-vivo machine perfusion systems to improve organ viability for transplantation.
Sweden XVIVO
Ypsomed Holding AG Logo
Develops injection systems for self-medication, partnering with pharma and biotech firms.
Switzerland YPSN

Talk to a Data Expert

Have a question? We'll get back to you promptly.